Successive Delivery of Drugs for the Treatment of Hepatitis C in 2024 as Part of... Tender

Procurement Summary

Country : Poland

Summary : Successive Delivery of Drugs for the Treatment of Hepatitis C in 2024 as Part of the Drug Program Financed by the National Health Fund for the Needs of the Wrocław Health Center Spzoz

Deadline : 10 Jan 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 93420069

Document Ref. No. : 747196-2023

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

The subject of the order is the successive delivery of drugs for the treatment of hepatitis C as part of the drug program financed by the National Health Fund for the needs of the Wrocław Health Center SPZOZ.

The order was divided into three separate Parts:

Part No. 1 - Delivery of the preparation includesGlecaprevir pibrentasvir

Part No. 1 of the order includes the supply of 220 packages (84 tablets/pack) of a preparation containing 100 mg of glecaprevir and 40 mg of pibrentasvir (Glecaprevirum Pibrentasvirum 100 mg 40 mg) in one tablet, indicated for the treatment of chronic inflammation virus infectionhepatitis C (HCV) in adults and adolescents aged 12 to Part No. 2 - Delivery of a preparation containing Sofosbuvir velpatasvir

Part No. 2 of the order includes the delivery of 75 packages (28 tablets/pack) of a preparation containing 400 mg of sofosbuvir and 100 mg of velpatasvir in one tablet, indicated in treatmentprevention of chronic hepatitis C virus (HCV) infection in adults and adolescents aged 12 to Part No. 3 - Delivery of a preparation containing Sofosbuvir velpatasvir and voxilaprevir

Part No. 3 of the order includes the delivery of 9 packages (28 tablets/pack) of the preparation containing 400mg sofosbuvir, 100 mg of velpatasvir and 100 mg of voxilaprevir in one tablet, indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults, used under the National Health Fund B.71 drug program - TREATMENT OF CHRONIC HEPATITIS C WITH INTERFERON-FREE THERAPY

...
Document Type: Contract Notice
Reference Number: Part No. 3
Contract Type: supplies
Doc Title: Successful delivery of drugs for the treatment of hepatitis C in 2024 under the drug program financed by the National Health Fund for the needs of the Wrocław Health Center SPZOZ
Dispatch Date: 2023-12-07
Publish Date: 2023-12-08
Submission Date: 2024-01-10

Documents

 Tender Notice